EMEA-003408-PIP02-24 - paediatric investigation plan
gallium (68Ga) boclatixafortide
PIPHuman
Key facts
- Active Substance
- gallium (68Ga) boclatixafortide
- Therapeutic area
- Endocrine disorders
- Decision number
- P/0213/2024
- PIP number
- EMEA-003408-PIP02-24
- Pharmaceutical form(s)
- Solution for injection
- Condition(s) / indication(s)
- Subtype diagnosis of primary aldosteronism
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Pentixapharm AG
E-mail: info@pentixapharm.com
Tel: +49 93199136076- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date